(NAFDAC Director General, Prof. Mojisola Adeyeye)
By Biola Lawal
Flowerbudnews: NAFDAC Stakeholders have commended Prof. Mojisola Adeyeye, noting that her leadership has strengthened Nigeria’s pharmaceutical sector through policy initiatives that promoted quality, safety, and local capacity development
The encomiums were heaped on Prof. Adeyeye by the stakeholders during the commissioning of Sam Pharmaceuticals Manufacturing Facility in Lagos.
Stakeholders at the event noted that NAFDAC’s 5+5 Policy has been instrumental in driving increased local manufacturing, contributing to a rise in domestic pharmaceutical production.
They further acknowledged that the Agency’s regulatory reforms and commitment to global best practices had enhanced investor confidence and supported industry growth.
On her part. Prof. Adeyeye noted that the commissioning of the Sam Pharmaceuticals Ltd’s manufacturing facility is ”a significant milestone in advancing local pharmaceutical production in Nigeria.’
The NAFDAC Boss reaffirmed her Agency’s commitment to fostering a robust and self-sufficient pharmaceutical sector.
She said that NAFDAC would continue to work hard to , ensure the availability of safe, effective, and affordable medicines for Nigerians.
Prof. Adeyeye emphasised that sustained collaboration between regulators and industry players remained critical to achieving national drug security and improved healthcare outcomes.